Chugai Pharmaceutical Aktie
| 40,09EUR | -0,45EUR | -1,11% |
WKN: 857216 / ISIN: JP3519400000
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 7 664 | 7 771 | 7 604 | 7 778 | 7 872 |
| Umsatz pro Mitarbeiter in Mio. EUR | 130,45 | 162,13 | 146,16 | 150,50 | 159,80 |
Bilanz (in Mio. JPY) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 1 063 661 | 1 336 537 | 1 366 426 | 1 606 043 | 1 740 758 |
| Summe Anlagevermögen | 475 033 | 533 221 | 566 121 | 602 330 | 727 837 |
| Summe Aktiva | 1 538 694 | 1 869 758 | 1 932 547 | 2 208 373 | 2 468 595 |
Bilanz (in Mio. JPY) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 350 677 | 445 371 | 306 966 | 306 874 | 442 861 |
| Summe Eigenkapital | 1 188 017 | 1 424 387 | 1 625 580 | 1 901 499 | 2 025 732 |
| Summe Passiva | 1 538 694 | 1 869 758 | 1 932 546 | 2 208 373 | 2 468 593 |
Adresse
| Nihonbashi Mitsui Tower, 15/F, 103-8324 Tokyo | |
| Telefon | +81 (3) 3281-6611 |
| Fax | +81 (3) 3281-6607 |
| Internet | https://www.chugai-pharm.co.jp |
Management
|
Boris El Zaitla
Director |
|
Fumio Tateishi
Independent Outside Director |
|
Hideo Teramoto
Independent Outside Director |
|
Hitoshi Iikura
Director & Senior Executive Officer |
|
Iwaaki Taniguchi
CFO, Director & Senior Executive Officer |
|
Junichi Ebihara
Senior Executive Officer & Manager-Legal Affairs |
|
Kazuhiko Nishi
Executive Officer & GM-Medical Affairs |
|
Kinuko Mitani
Independent Outside Director |
|
Kotaro Yahagi
Manager-Finance & Accounting |
|
Manabu Onozawa
Head-Business Development & CVF |
|
Masayoshi Higuchi
Auditor |
|
Naoya Fujiwara
Head-External Relations & Research |
|
Osamu Okuda
President, CEO & Representative Director |
|
Shigehiro Yamada
Auditor |
|
Shinji Hidaka
Head-Sales & Medical Affairs |
|
Shinya Takuma
Executive Officer & GM-Production Technology |
|
Shoko Kimijima
Head-Legal Affairs, Risk & Compliance |
|
Theresa A. Graham
Non-Executive Director |
|
Thomas Schinecker
Director |
|
Yoshiyuki Yano
Senior Executive Officer & Head-Personnel |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.